Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).
In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).
MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.
MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.
Choose MenaQ7® to support your heart health claims with science!
Latest news & videos
- Lynside®
- News
- Quatrefolic
- Apr 19, 2024
Find out how female fertility can be enhanced
Infertility can be an important concern for couples. In the world, around one in...
- Lynside®
- News
- Quatreflora
- Apr 02, 2024
Gnosis Showcases Innovative Ingredients at Food Ingredients China 2024
This 20th of March, Gnosis by Lesaffre is thrilled to participate in Food Ingredients...
- Lynside®
- News
- Trends
Lynside® for Beauty Supplements
Beauty supplements is an important market on the rise. Discover on this video how...
